Details

Idejna zasnova ureditve jedra Pivke : diplomsko delo
ID Ota, Janja (Author), ID Kučan, Ana (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (19,46 MB)
MD5: C91417D27C7EAAEA1DF286DF58C30601

Language:Slovenian
Keywords:krajinska arhitektura, idejna zasnova, prometna ureditev, javni prostor, zelene površine, Pivka
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:BF - Biotechnical Faculty
Place of publishing:Ljubljana
Publisher:[J. Ota]
Year:2016
Number of pages:X, 68 f.
PID:20.500.12556/RUL-116267 This link opens in a new window
UDC:711.451:712.2(497.4Pivka)(043.2)
COBISS.SI-ID:8584313 This link opens in a new window
Publication date in RUL:24.05.2020
Views:3706
Downloads:215
Metadata:XML DC-XML DC-RDF
:
OTA, Janja, 2016, Idejna zasnova ureditve jedra Pivke : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : J. Ota. [Accessed 17 July 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=116267
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Conceptual design of Pivka center
Keywords:landscape architecture, conceptual design, transport infrastructure, open public space, green spaces

Similar documents

Similar works from RUL:
  1. Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
  2. Metastatic EMT phenotype is governed by microRNA-200-mediated competing endogenous RNA networks
  3. Vloga cisteinskih katepsinov B in X in njunih inhibitorjev pri epitelno-mezenhimskem prehodu tumorskih celic
  4. Izolacija in karakterizacija tumorskih matičnih celic iz celičnih linij raka dojke in ovrednotenje izražanja katepsinov B in X v njih
  5. Določanje prisotnosti krožečih tumorskih celic v periferni krvi bolnikov po RO-resekciji raka debelega črevesa in danke
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back